Cargando…
Microarray Technology Applied to Human Allergic Disease
IgE antibodies serve as the gatekeeper for the release of mediators from sensitized (IgE positive) mast cells and basophils following a relevant allergen exposure which can lead to an immediate-type hypersensitivity (allergic) reaction. Purified recombinant and native allergens were combined in the...
Autor principal: | Hamilton, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374363/ https://www.ncbi.nlm.nih.gov/pubmed/28134842 http://dx.doi.org/10.3390/microarrays6010003 |
Ejemplares similares
-
Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004) -
Diagnostic evaluation of food-related allergic diseases
por: Eckman, John, et al.
Publicado: (2009) -
The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature
por: Callaway, Jonathan L A, et al.
Publicado: (2013) -
The use of microarray technologies in clinical oncology
por: Gabriele, L, et al.
Publicado: (2006) -
Mechanisims of asthma and allergic disease – 1076. Identification of genes related to seasonal allergic rhinitis by microarray analysis
por: Imoto, Yoshimasa, et al.
Publicado: (2013)